Zobrazeno 1 - 10
of 33
pro vyhledávání: '"F. E. Cotter"'
Autor:
I. A. Auer, T. C. Greiner, Randy D. Gascoyne, J. M. Conners, Douglas E. Horsman, Warren G. Sanger, F. E. Cotter
Publikováno v:
Annals of Oncology. 8:979-985
Summary Background Low grade malignant lymphomas arising from mucosa associated lymphoid tissue (MALT) represent a distinct clinicopathological entity. The cytogenetic findings and molecular genetics of MALT lymphomas remain minimally defined. Cytoge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65ccd174e26fcc1e7f0ae989039ef0ce
https://doi.org/10.1023/a:1008202303666
https://doi.org/10.1023/a:1008202303666
Autor:
C F, Pocock, F E, Cotter
Publikováno v:
Methods in molecular medicine. 6
Chromosome rearrangements of chromosome 11 at band 1 1q23 are detected in a high proportion of infant leukemias (l yr) as well as childhood and adult acute leukemlas of both myelold and lymphold types. Molecular and cytogenetic analysis of these tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::77a251b22b64a753a890a276cd3a1359
https://pubmed.ncbi.nlm.nih.gov/21380697
https://pubmed.ncbi.nlm.nih.gov/21380697
Publikováno v:
British journal of haematology. 112(3)
Bcl-XL, a member of the Bcl-2-related anti-apoptosis protein family, antagonizes a diverse range of apoptosis-inducing stimuli by preventing mitochondrial permeability transition, release of apoptogenic factors including cytochrome C, and caspase act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e3d8389b2eda1ac24a1a707e7bb4290
https://pubmed.ncbi.nlm.nih.gov/11260076
https://pubmed.ncbi.nlm.nih.gov/11260076
Autor:
D A, Fennell, F E, Cotter
Publikováno v:
Cytometry. 39(4)
Cytofluorometric analysis allows single-cell resolution of all-or-none programmed cell death (apoptosis) responses and permits direct measurement of cumulative frequency distributions (CFDs) of apoptosis sensitivity from which the median apoptosis to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c0f11ec0bbc13e08b85d4356ac7190d6
https://pubmed.ncbi.nlm.nih.gov/10738279
https://pubmed.ncbi.nlm.nih.gov/10738279
Autor:
F E, Cotter
Publikováno v:
Seminars in hematology. 36(4 Suppl 6)
Many tumor cells are inherently resistant to curative treatment due to an altered pattern of gene expression. It is an attractive and logical proposition to use this difference within the lymphoma cell to eradicate the malignant process. One such new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::31ae24363b5312d0cf2a01814fb67e65
https://pubmed.ncbi.nlm.nih.gov/10530711
https://pubmed.ncbi.nlm.nih.gov/10530711
Autor:
F I, Raynaud, R M, Orr, P M, Goddard, H A, Lacey, H, Lancashire, I R, Judson, T, Beck, B, Bryan, F E, Cotter
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 281(1)
An 18-mer full-phosphorothioate oligonucleotide with sequence antisense to the first six codons of the open reading frame of bcl-2 (G3139) has shown efficacy against the DoHH2 lymphoma implanted in severe combined immunodeficient mice. This study eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::36634859ce63422981aa504b1ea21ab1
https://pubmed.ncbi.nlm.nih.gov/9103525
https://pubmed.ncbi.nlm.nih.gov/9103525
Autor:
F E, Cotter
Publikováno v:
Hematological oncology. 15(1)
The potential ability of antisense oligonucleotides to downregulate the expression of oncogenes involved in lymphoma, with minimal toxicity can be achieved. The possibility of combining antisense therapy such as BCL-2 antisense with chemotherapy will
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f3d9a04d0448ce3e148d7fb72d8552aa
https://pubmed.ncbi.nlm.nih.gov/9378470
https://pubmed.ncbi.nlm.nih.gov/9378470
Autor:
F E, Cotter
Publikováno v:
Cancer surveys. 30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::532a1fb518637b961c5b6c36b9cad5cb
https://pubmed.ncbi.nlm.nih.gov/9547999
https://pubmed.ncbi.nlm.nih.gov/9547999
Autor:
S, Devereux, F E, Cotter
Publikováno v:
Bailliere's clinical haematology. 9(4)
The availability of molecular genetic technology has opened up a large range of potential strategies for the treatment of lymphoma. In the immediate future it is likely that these techniques will be of most use in the evaluation of procedures such as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f2c8677383b399399d64d16a7cf48999
https://pubmed.ncbi.nlm.nih.gov/9138619
https://pubmed.ncbi.nlm.nih.gov/9138619